Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Haupt Pharma AG
Pharmaceutical Preparation ManufacturingGermany
Last verified 3 months agohaupt-pharma.com
Haupt Pharma AG, a leading entity in the pharmaceutical preparation manufacturing industry, is headquartered in Germany. Renowned for its expertise in developing and producing high-quality medicinal formulations, the company serves a broad international market, with significant operations across Europe and beyond. Founded in 2004, Haupt Pharma has established a strong reputation for innovation and reliability within the pharmaceutical sector.
Specialising in the manufacturing of sterile and non-sterile pharmaceutical products, Haupt Pharma’s core offerings include customised solutions for pharmaceutical companies, including liquids, powders, and semi-solids. Its commitment to quality and compliance with stringent industry standards has positioned it as a trusted partner in the healthcare supply chain. With a focus on continuous improvement and technological advancement, Haupt Pharma AG remains a notable player in the global pharmaceutical manufacturing landscape.
23
DitchCarbon score
-19 vs industry average
Haupt Pharma AG’s score of 23 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Haupt Pharma AG?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Haupt Pharma AG yet.
Haupt Pharma AG's reported carbon emissions
Haupt Pharma AG, a German pharmaceutical preparation manufacturer, is committed to climate action. While no specific carbon emissions data for Haupt Pharma AG is available, its corporate family has established a significant climate commitment. Medac Pharma LLP, a related entity, has committed to achieving Net Zero emissions by 2045. Furthermore, Medac Pharma LLP aims to reduce carbon emissions by 30% by 2045, with a baseline year of 2023. These targets apply across all scopes of emissions.
Assessing Haupt Pharma AG as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Haupt Pharma AG and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Haupt Pharma AG’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Haupt Pharma AG yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
Inherited from Aenova Holding GmbHSee details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Haupt Pharma AG3 months ago
23
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more